News
Drug and biotech news
Trade press headlines, FDA announcements, new drug and biologic approvals, and Class I recalls, newest first. Refreshed hourly. Stories open on the publisher's site.
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
All areasOncologyHematology and blood cancersCardiovascular and metabolicNeurologyPsychiatryImmunology and inflammationInfectious disease and vaccinesRespiratoryRare and genetic diseaseKidney and urologyGastroenterology and liverEndocrinology and women's healthOphthalmologyDermatologyPain and anesthesia
1 stories
Tagged Neurology from the headline and teaser, so some stories may be missed or misfiled.
- Trade pressSTAT (pharma)Nov 19, 2026STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in China
Big drugmakers tell U.S. House committee they will halt clinical trials at some hospitals in China.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.